GlassScriptPhysician profile
Rock Navarkal
NPI 1073703484
$1,377.68
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,241 · 2020: $48.31 · 2022: $43.11 · 2023: $28.63 · 2024: $16.77.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $45.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $45.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $578.55 | 2019 | |
| Nevro Corp. | $247.98 | 2019 | |
| Stimwave Technologies Incorporated | $118.09 | 2019-2020 | |
| Boston Scientific Corporation | $102.90 | 2019 | |
| Novartis Pharmaceuticals Corporation | $96.19 | 2019 | |
| Collegium Pharmaceutical, INC. | $60.89 | 2019-2023 | Xtampza, Belbuca |
| Sentynl Therapeutics, INC. | $47.35 | 2019-2020 | |
| Medtronic, INC. | $43.11 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $20.95 | 2019 | |
| Convatec INC. | $16.77 | 2024 | |
| Biodelivery Sciences International, INC. | $15.06 | 2019 | |
| Orthogenrx INC. | $15.01 | 2020 | |
| Pfizer INC. | $14.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rock Navarkal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.